Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Deimination of the myelin basic protein decelerates its proteasome-mediated metabolism.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
MRI Patterns of Isolated Lesions in the Medulla Oblongata.
HIV-1 Tat Inhibits Autotaxin Lysophospholipase D Activity and Modulates Oligodendrocyte Differentiation.
Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
Evidence of Hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system.
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis.
Postreading Self-Assessment and CME Test.
Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis.
Pre-clinical disease activity in multiple sclerosis- a prospective study on cognitive performance prior to first symptom.
Taste dysfunction in multiple sclerosis.
Natalizumab: a new therapy for acute ischemic stroke?
N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
Atypical inflammatory demyelinating syndromes of the CNS.
T lymphocyte apoptosis in systemic lupus erythematosus patients.
FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases.
Increased regional gray matter atrophy and enhanced functional connectivity in male multiple sclerosis patients.
Perturbed cholesterol homeostasis in aging spinal cord.
Divided visual attention: A comparison of patients with multiple sclerosis and controls, assessed with an optokinetic nystagmus suppression task.
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients.
Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
Intravital assessment of myelin molecular order with polarimetric multiphoton microscopy.
Pages
« first
‹ previous
…
749
750
751
752
753
754
755
756
757
…
next ›
last »